Generic Name
Selegiline
Brand Names
EMSAM, Zelapar
FDA approval date: August 02, 1996
Classification: Monoamine Oxidase Inhibitor
Form: Patch, Tablet, Capsule
What is EMSAM (Selegiline)?
EMSAM is a monoamine oxidase inhibitor indicated for the treatment of adults with major depressive disorder . EMSAM ® is a monoamine oxidase inhibitor indicated for the treatment of major depressive disorder .
Approved To Treat
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
There is no clinical trials being done for this treatment